Cancer BiologybioRxivPreprint
Integrated Patient-Derived Xenograft and Patient-Derived Cell Models Reveal Therapeutic Vulnerabilities Beyond Standard-of-Care Therapy in Endometrial Cancer
Tianyue Li, Fang Huang, XJ Huang…·Shujie Yang
This study establishes a PDX and PDC platform to identify therapeutic vulnerabilities in endometrial cancer, revealing that epigenetic combination therapies show significant antitumor activity.
DOI 10.64898/2026.07.24.740568